Covered recipient · General Payments record
MAUDE CARMEL
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$3,194.38
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $759.87 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $540.35 | 7 |
| ABBVIE INC. | $56.09 | 2 |
| Sumitomo Pharma America, Inc. | $43.03 | 2 |
| BLUEWIND MEDICAL | $40.31 | 1 |
| C. R. BARD, INC. & SUBSIDIARIES | $27.97 | 1 |
| Innovation Technologies Inc | $24.66 | 1 |
| COLOPLAST CORP | $14.24 | 1 |
| Antares Pharma, Inc. | $13.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.80 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103417833 | CMS |
| ABBVIE INC. | $25.29 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103417835 | CMS |
| Antares Pharma, Inc. | $13.22 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146452094 | CMS |
| BLUEWIND MEDICAL | $40.31 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126545182 | CMS |
| C. R. Bard, Inc. & Subsidiaries | $27.97 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130838518 | CMS |
| COLOPLAST CORP | $14.24 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117451300 | CMS |
| Innovation Technologies Inc | $24.66 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130819667 | CMS |
| Medtronic, Inc. | $4.60 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479669 | CMS |
| Medtronic, Inc. | $107.49 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479677 | CMS |
| Medtronic, Inc. | $169.12 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479675 | CMS |
| Medtronic, Inc. | $3.84 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479671 | CMS |
| Medtronic, Inc. | $78.12 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479673 | CMS |
| Medtronic, Inc. | $170.00 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479679 | CMS |
| Medtronic, Inc. | $7.18 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119479681 | CMS |
| Sumitomo Pharma America, Inc. | $19.34 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148835349 | CMS |
| Sumitomo Pharma America, Inc. | $23.69 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148835351 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.